Michal Graff Mitzmacher
Chief Technology Officer
Pharmaceutical sciences
Elastagen
Australia
Biography
Michal has driven the transition of Elastagen’s technology from proof of concept production runs through scale up to commercial production and industrial processes; enabling Elastagen’s unique tropoelastin based materials to be produced to the required economies of scale. In addition, Michal has been central to Elastagen’s partnering activities with responsibility for the capture, communication and transfer of Elastagen’s technology to and from partner facilities.
Research Interest
Pharmaceutical sciences